Our Expertise
The reimbursement, regulatory and technological environments in the healthcare sector are constantly evolving. Concurrently, demand for effective and affordable solutions is being driven primarily by the aging global population. At Canaccord Genuity, we are looking at exciting potential returns as quality innovation to serve a growing market is provided.
That is one of the reasons why we expanded our Healthcare and Life Sciences practice in 2015 with a team dedicated to high growth healthcare information technology companies. By combining our global resources and local expertise, we provide innovative thinking and ideas to help you navigate this dynamic sector.
Our clients are public and private healthcare companies from across all sub sectors. We have in-depth expertise across the following:
- Biopharmaceuticals
- Biotechnology
- Cannabis
- Diagnostics
- Digital & Tech Enabled Health
- HC Services
- Med Tech
Recent Healthcare Transactions
Meet Our Healthcare Team
We believe in developing and nurturing long term client partnerships. Our Healthcare sector team is keen to explore new opportunities and can offer our clients access to global capital markets due to our expertise across multiple regions. That means we can offer our clients highly relevant services. Please get in touch if you’d like to find out more.
Eugene Rozelman
Managing Director & Co-Head of Healthcare Investment Banking, Head of U.S. Biotech & Spec Pharma Investment Banking
Voir la biographie
Matt Steere
Managing Director & Co-Head Healthcare Investment Banking, Medical Technologies & Diagnostics
Voir la biographie
Steve Winokur
Managing Director, Head of Canadian Healthcare & Head of Strategic Planning
Voir la biographie